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ARTICLE
Split selectable markers
Nathaniel Jillette1,4, Menghan Du1,2,4, Jacqueline Jufen Zhu1, Peter Cardoz1 & Albert Wu Cheng 1,2,3*
Selectable markers are widely used in transgenesis and genome editing for selecting engi-
neered cells with a desired genotype but the variety of markers is limited. Here we present
split selectable markers that each allow for selection of multiple “unlinked” transgenes in the
context of lentivirus-mediated transgenesis as well as CRISPR-Cas-mediated knock-ins. Split
marker gene segments fused to protein splicing elements called “inteins” can be separately
co-segregated with different transgenic vectors, and rejoin via protein trans-splicing to
reconstitute a full-length marker protein in host cells receiving all intended vectors. Using a
lentiviral system, we create and validate 2-split Hygromycin, Puromycin, Neomycin and
Blasticidin resistance genes as well as mScarlet fluorescent proteins. By combining split
points, we create 3- and 6-split Hygromycin resistance genes, demonstrating that higher-
degree split markers can be generated by a “chaining” design. We adapt the split marker
system for selecting biallelically engineered cells after CRISPR gene editing. Future engi-
neering of split markers may allow selection of a higher number of genetic modifications in
target cells.
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Selectable markers, such as antibiotic resistance or fluor-escent protein genes, are often used in genetic engineeringto isolate cells with desired genotypes1. However, there are a
limited number of well-characterized antibiotic resistance genes
for use in eukaryotic cells and fluorescent proteins whose spectra
can be unambiguously differentiated by commonly used equip-
ment is similarly limited. Researchers often run into the problem
of not having enough choices of selectable markers if they wish to
incorporate multiple transgenes into a cell. On the other hand,
selection with multiple antibiotics at the same time is often harsh
to cells. “Selectable marker recycling” can provide a work-around
but is unwieldy, requiring multiple rounds of transgenesis,
selection and removal of markers2.
To allow multiple transgene selection with a single scheme, we
create here split antibiotics resistance and fluorescent protein
genes. In this system, a gene encoding an antibiotic resistance or
fluorescent protein is split into two or more segments and fused
to inteins (“markertrons”) that can be rejoined by protein trans-
splicing3 (Fig. 1). Each markertron is inserted onto a transgenic
vector carrying a specific transgene. Delivery of transgenic vectors
containing a set of markertrons yields cells that harbor either a
subset or a complete set of the markertrons. Only cells with a
complete set of markertrons produce a fully reconstituted marker
protein via protein splicing and thus passes through selection
while cells with partial sets of markertrons are eliminated,
achieving co-selection of cells containing all intended transgenes.
Results
Intein-split antibiotic resistance (Intres) genes. We began by
engineering 2-markertron intein-split resistance (Intres) genes for
double transgenesis. Since flanking residues and local protein
folding can affect efficiency of intein-mediated trans-splicing, we
set out to identify split points in each of the four commonly used
antibiotic resistance genes compatible with two well-characterized
split inteins derived from NpuDnaE4,5 and SspDnaB6. To
facilitate assessment of the effectiveness of double transgenic
selection, we cloned markertrons onto lentiviral vectors expres-
sing TagBFP or mCherry fluorescent proteins as test transgenes
(Fig. 2a). Viral preparations were transduced into U2OS cells,
which were then split into replicate plates with non-selective or
selective media. Following appropriate passages for antibiotics
selection, the two cell cultures were analyzed by flow cytometry.
For Hygromycin resistance (HygroR) gene, one “native” SspDnaB
split point (SspDnaB-200=G200:S201; Plasmid pair 5,6) with
flanking residues “GS” and one “native” NpuDnaE split point
(NpuDnaE-89= Y89:C90; Plasmid pair 3, 4) with “YC” residues
were tested (Supplementary Fig. 1a). Both enabled successful
selection when both N- and C-markertrons were transduced
yielding >95% BFP+mCherry+ double transgenic cells in
selected cultures compared to <40% double-positive cells in non-
selected culture (Fig. 2b; Plasmid pairs 3, 4 and 5, 6). Cells
transduced with either of the single markertrons did not survive
Hygromycin selection. In contrast, double transgenesis with
conventional full-length non-split HygroR vectors only allowed
for ~20% enrichment of BFP+mCherry+ cells (Plasmid pairs
97,98) at lower titers and for up to ~50% at higher titers. We
screened three additional potential split points (NpuDnaE-52=
52 S:53 C; Plasmid pair 7,8), (NpuDnaE-240= 240 A:241 C;
Plasmid pair 9,10), and (NpuDnaE-292= 292 R:293 C; Plasmid
pair 11,12) for NpuDnaE with the obligatory cysteine residue on
the C-extein junction and a residue on the N-extein junction
reported to support substantial trans-splicing activities7. We also
tested six additional NpuDnaE split points (NpuDnaE-69, 131,
171, 218, 259, and 277) by inserting an “artificial” cysteine on the
C-extein junction to support splicing at ectopic sites yielding
additional split points. In total, eight out of eleven split points
tested supported Hygromycin selection (Fig. 2b). Two of the
Hygro Intres designs (NpuDnaE-131 and 292) failed to provide
resistance in two of the four replicate experiments at lower titers,
while three designs (NpuDnaE-218, 259, and 277) failed to pro-
vide resistance in any experiments. These positions may reside
within less efficient splicing sequence and structural contexts or
may disrupt folding of the HygroR protein upon reconstitution.
Indeed, western blot analysis using terminally tagged markertron
fragments revealed that among split points 52, 68, 89, 131, and
171, trans-splicing is least active at split point 131 (Supplemen-
tary Fig. 1b, lane 5). This is consistent with its failure to con-
sistently provide resistance at a lower titer (Fig. 2b). In addition,
the insertion of the artificial cysteine at the NpuDnaE-69, 131,
and 171 C-markertrons is required for protein splicing mediated
by NpuDnaE intein at these positions (Compare lanes 2/3, 5/6,
and 7/8), consistent with a well-established requirement7.
Nonetheless, the six successful designs validate our screening
strategy and demonstrate that HygroR is amenable to splitting at
different positions spanning a large portion of the protein.
Similarly, for Puromycin resistance (PuroR) (Fig. 3a), Neomycin/
G418 resistance (NeoR) (Fig. 3b) or Blasticidin resistance (BlastR)
(Fig. 3c) genes, we identified four, two, and one functional 2-split
Intres pair(s), respectively. In all of these cases, cells transduced
with single markertrons did not survive selection, while cells
transduced with both yielded 88–100% double transgenic cells in
selective cultures compared to <50% in non-selective cultures.
Details of the split points of Intres genes and plasmids are pre-
sented in Supplementary Figs. 1–4 and Supplementary Table 1.
To facilitate adoption of Intres markers, we created Gateway-
compatible lentiviral vectors for convenient restriction-ligation-
independent LR clonase recombination of transgenes8 (Supple-
mentary Fig. 5). We tested the functionality of these vectors by
recombining TagBFP and mCherry, respectively to the N- and C-
Intres vectors and found robust selection of double transgenic
cells (Supplementary Fig. 5b). One potential utility of Intres
Mar
DeliveryPr PrMarN
Transgene 1
Transgene 1
Transgene 1 Transgene 2
Transgene 2
Transgene 2
IntN
MarN IntN
MarN IntN IntC kerC
IntC kerC
IntC kerC
ker
Marker
Selection
Fig. 1 Split selectable marker for co-selection of two separate transgenic
vectors. The coding sequence of a selectable marker is split into an N-
terminal fragment (MarN) and a C-terminal fragment (kerC) and separately
cloned upstream of an N-terminal fragment of a split intein (IntN) and
downstream of a C-terminal fragment of the split intein (IntC), respectively,
on two different vectors each carrying a different transgene. These vectors
are delivered to cells yielding sub-populations of cells containing either one,
or both of the vectors. Only cells with both vectors expressing the two
intein-split selectable marker fragments (“markertrons”) undergo protein
trans-splicing to reconstitute a full-length selectable marker, allowing
specific selection and enrichment of the double transgenic cells
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12891-2
2 NATURE COMMUNICATIONS |         (2019) 10:4968 | https://doi.org/10.1038/s41467-019-12891-2 | www.nature.com/naturecommunications
vectors is to install different fluorescent markers in cells to label
different cellular compartments. To explore this application, we
cloned in NLS-GFP and LifeAct-mScarlet9, which label nucleus
and F-actin, respectively, by Gateway recombination to conven-
tional full-length (FL) non-split Hygromycin selectable vectors or
2-split Hygromycin Intres vectors. We transduced cells with
either sets of plasmids and subjected them to antibiotic selection
(Supplementary Fig. 5c). The sample transduced with non-split
selectable plasmids contained both singly and doubly labeled
cells, while cell transduced with Intres plasmids were all doubly
labeled.
Split mScarlet fluorescent genes for double transgenesis. To test
whether split fluorescent markers can be used for transgene
selection, we screened for NpuDnaE split points in the mScarlet
fluorescent protein (Supplementary Figs. 6 and 7a) and identified
four split points allowing for >96% enrichment of double trans-
genic cells and three other split points enabling >60% enrichment
of double transgenic cells in an mScarlet-gated population,
compared to <20% double transgenic cells in non-gated popula-
tion (Supplementary Fig. 7b, c).
Three-split Hygromycin Intres for triple transgenesis. With the
split points identified for 2-markertron Intres genes, we set out to
engineer higher degree split markers. We tested combinations of
splits points to partition a marker gene into three or more
markertrons to allow for co-selection of more than two
“unlinked” transgenes with one antibiotic (Fig. 4a, b). To identify
pairs of split points that would allow such an “Intres chain”, we
cloned 3-split markertrons into three lentiviral vectors each car-
rying one of three fluorescent transgenes TagBFP, EGFP, or
mCherry, that will allow us to assess effectiveness of selection by
flow cytometry (Fig. 4c). Since the Hygromycin resistance gene is
the longest and provides the most split points for testing, we
focused on engineering 3-split Hygromycin Intres. We tested two
3-split Hygromycin Intres using two intervening NpuDnaE
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Fig. 2 Split Hygromycin resistance genes for co-selection of two separate transgenic vectors. a To screen for split points compatible with inteins for an
antibiotic resistance gene, we identified potential split points according to the junctional requirement for the type of intein tested, then cloned the
corresponding N- and C-terminal fragments to the split intein scaffolds on lentiviral vectors equipped with TagBFP or mCherry fluorescent proteins, which
serve as our test transgenes to evaluate selection efficiency. These are delivered into cells via lentiviral transduction. The cells were then split into replicate
plates, one subjected to antibiotic selection while the other was maintained in non-selective media. Following antibiotic selection, the replicate cultures
were analyzed by flow cytometry. b 2-split Hygromycin (Hygro) intein-split resistance (Intres) genes. Top schematics shows the split points tested for
Hygromycin resistance gene. The last residue of the N-terminal fragment is indicated on top of the lollipops. Circle lollipops represent split points using
NpuDnaE intein while square lollipops represent those using SspDnaB intein. Crossed-out and shaded lollipops indicate split pairs that failed to endow cells
with Hygromycin resistance. The column plots below show the percentages of double transgenic cells (BFP+mCherry+) in the non-selective (white
portion) and the selective cultures (total column height=white+ blue) quantified by flow cytometry, from samples transduced with 25 μL virus (middle
column plot) or 100 μL virus (bottom column plot). Experiments were conducted in quadruplicate, with each column representing a completely
independent virus preparation, transduction and selection. The 25 μL and 100 μL data in the same x-position represent the sister cultures introduced with
25 μL or 100 μL of the same virus preparations, respectively. ND: No data, experiment not performed; X: No survival. Horizontal asterisks indicate statistical
significance by one-way ANOVA test on the percentages of double-positive cells in the selected cultures of the specific split marker vs those in the non-
split marker (n.s., non-significant; *p < 0.05, **p < 0.01, ***p < 0.001). Vertical asterisks indicate statistical significance by paired two-sided t-test on the
percentages of double-positive cells in the selected cultures vs non-selected cultures within each transfection group (n.s., non-significant; *p < 0.05, **p <
0.01, ***p < 0.001)
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inteins (i.e., homogeneous intein), two using NpuDnaE for the
first intein and SspDnaB for the second intein, as well as two
using SspDnaB for the first intein and NpuDnaE for the second
intein (i.e., heterogeneous “orthogonal” inteins) (Fig. 4d). The
four heterogeneous-intein 3-split Hygromycin Intres enabled
95–100% triple transgenic selection and the two homogeneous-
intein Hygro Intres enabled 74–99% triple transgenic selection in
Hygromycin-selected cultures compared to <20% in non-selected
cultures. Samples with “leave-one-out” transduction did not yield
any viable cells after Hygromycin selection while cells transduced
with non-split Hygromycin vectors yielded only 7–17% triple
transgenic cells after selection. The observation that 3-split Intres
designs using two orthogonal inteins yielded more consistent
results than those using the same inteins for the two split points
suggest that the use of the same inteins for joining multiple split
points may result in artifacts caused by combinatorial splicing
that generates “misjoined” fragments. To facilitate the use of 3-
split Intres, we created Gateway compatible lentiviral vectors with
three of the 3-split Hygromycin Intres (Supplementary Fig. 8a).
Three sets of these vectors were each tested by recombining
TagBFP (as transgene 1), EGFP (as transgene 2) and mCherry (as
transgene 3) into the N-, M-, and C-Intres Gateway destination
vectors. Lentiviruses derived from the resultant vectors were used
to transduce U2OS cells, which were then split into Hygromycin
selective or non-selective media (Supplementary Fig. 8b). Two
weeks after selection, cells were analyzed by flow cytometry. All
three sets of 3-split Hygromycin Intres plasmids support triple
transgenic cell selection of >97% compared to <40% in the non-
selected cultures (Supplementary Fig. 8c).
Application of Intres in CRISPR-Cas-mediated knock-in.
Another potential application of split selectable markers is to
facilitate genome engineering and editing via the CRISPR-Cas
system10. Although gene knockout based on NHEJ-mediated
insertions/deletions (indels) occurs at high frequency, precise
editing and knock-in based on homology directed repair (HDR)
using exogenous repair templates are inefficient11. We tested
whether split selectable markers can be used to select for cells
with CRISPR-mediated biallelic knock-in at the AAVS1 locus12.
We constructed targeting constructs with homology arms flank-
ing the target site, and splice acceptor-2A peptide to trap the
markertrons within intron one of the host gene PPP1R12C.
However, we did not obtain any live cells after CRISPR-Cas
knock-in experiments in HEK293T cells using these targeting
constructs and two weeks of antibiotic selection. We suspected
that the endogenous promoter of the host gene PPP1R12C might
not drive sufficient expression of markertrons to reconstitute
enough antibiotic resistance protein to counter the antibiotic. We
thus tested an alternative strategy to express Intres markertrons
using the TetO promoter which allows activity to be tuned by
doxycycline (dox). To allow comparison of Intres-mediated
biallelic selection versus full-length (FL) non-split selectable
markers, we implemented several different targeting construct
designs. First, we drove expression of a full-length (FL) resistance
gene (e.g., Hygro) together with rtTA under a constitutive EF1a
promoter and a separate test Intres (e.g., Blast Intres) under a
dox-inducible TetO promoter (Supplementary Fig. 9b, Plasmids
109 and 110). This allows comparison of full-length and split
selectable markers within the same constructs. To allow valid
comparison of full-length versus split markers driven by the same
TetO promoter, we constructed two similar plasmids 107 and 108
(cf. Plasmids 109 and 110), wherein the full-length antibiotic
resistance gene (Blast) is placed downstream of the TetO pro-
moter. To enable single-cell quantification of biallelic targeting
and to demonstrate the feasibility of incorporating two transgenes
into two AAVS1 alleles, we appended EGFP and mScarlet fluor-
escent genes downstream of the test split or non-split markers via
the self-cleaving 2A peptide. Similarly, to test Hygro Intres, we
swapped the EF1a and TetO-driven markers so that FL Hygro or
Hygro Intres were placed downstream of TetO and FL Blast
downstream of EF1a (Supplementary Fig. 9c, d; Plasmids
111–114). We co-transfected pX330-AAVS1 (Plasmid 106)
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Fig. 3 Two-Split Puromycin, Neomycin and Blasticdin resistance genes. a 2-split Puromycin (Puro) Intres genes. Top schematics show split points tested for
Puromycin resistance (PuroR) genes while bottom column plot shows percentages of double transgenic cells in the non-selective (white portion) and the
selective cultures (total column height=white+ brown). Adjacent columns represent results from replicate experiments. X: No survival. b 2-split
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0.01, ***p < 0.001)
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containing Cas9 and sgRNA targeting AAVS1, and the different
pairs of targeting constructs (TC) into HEK293T cells, split into
triplicate doxycycline-containing media without antibiotics, with
Blasticidin, or with Hygromycin at the subsequent passages. Two
weeks after selection, we analyzed the cultures for biallelic tar-
geting by flow cytometric measurement of GFP and RFP fluor-
escence (Supplementary Fig. 9e). As expected, non-selected
cultures harbored a small fraction (<1%) of biallelic knock-in
GFP+/RFP+cells (Supplementary Fig. 9e; Selection=None).
Selection of antibiotics where corresponding FL antibiotic resis-
tance genes were present on targeting constructs yielded <30%
biallelic knock-in cells (Supplementary Fig. 9e; Blast: TC a, c, d;
Hygro: TC a, b, c). In contrast, selection by antibiotics where
corresponding Intres are present on the targeting constructs
yielded 75% (Supplementary Fig. 9e; Blast Intres: TC b) and 88%
(Supplementary Fig. 9e; Hygro Intres: TC d) biallelic knock-in
cells. Selection for an additional two weeks allowed split Blast and
Hygro TCs to achieve 96.5% and 97.0% biallelic knock-in,
respectively (Supplementary Fig. 9f, g). We next tested biallelic
engineering in KOLF2-C1 human induced pluripotent stem cells
(hiPSCs), which are karyotypically normal with a stable diploid
genome13 (Fig. 5). The full-length non-split Blast targeting con-
structs (Fig. 5a) and 2-split Blast Intres targeting constructs
(Fig. 5b) were tested for selection of biallelically modified clones.
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(total column height=white+ blue) cultures for the 3-split Hygromycin Intres indicated by the numbers below. Horizontal asterisks indicate statistical
significance by one-way ANOVA test on the percentages of triple-positive cells in the selected cultures of the specific split marker vs those in the non-split
marker (n.s., non-significant; *p < 0.05, **p < 0.01, ***p < 0.001). Vertical asterisks indicate statistical significance by paired two-sided t-test on the
percentages of triple-positive cells in the selected cultures vs non-selected cultures within each transfection group (n.s., non-significant; *p < 0.05, **p <
0.01, ***p < 0.001)
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Purified Cas9 proteins were complexed with synthetic sgRNA to
form Cas9 ribonucleoprotein (RNP) and co-nucleofected with the
targeting constructs into KOLF2-C1, followed by dox-induction
and antibiotic selection. Surviving colonies were picked into
separate wells for establishing single-cell clones. Genotyping PCR
revealed that targeting using non-split Blast resistance gene
generated only 8% biallelic clones, while targeting using Blas-
ticidin Intres yielded exclusively (100%) biallelically modified
clones (Fig. 5c, d), showing both fluorescent signals (Fig. 5e)
indicative of the targeting by each targeting construct at the two
alleles of AAVS in these hiPSCs.
Selection of four or more transgenes with Intres. The utility of
Intres may become more apparent in cases where more than three
transgenes are to be selected. As we have observed in our 3-split
Hygromycin Intres engineering exercise that the use of a set of
orthogonal inteins represent a better design for a more robust
split marker, we tested four other inteins (gp411, gp418, NrdJ1,
IMPDH1)14 in splitting HygroR or PuroR. We identified addi-
tional functional splits of HygroR and PuroR at different positions
(Supplementary Figs. 10 and 11). Some of these additional Intres
were further adapted to the Gateway cloning system (Supple-
mentary Figs. 12 and 13). To directly observe protein splicing as
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mScarlet (plasmid 110) separated by a self-cleaving 2A peptide sequence. Cas9 ribonucleoprotein was formed in vitro by complexing purified Cas9
proteins with synthetic sgRNA targeting AAVS locus, introduced to hiPSCs together with targeting constructs by nucleofection, subsequently subjected to
dox-induction and antibiotic selection, and finally cloned by colony picking and analyzed for allelic modification. c Genotyping PCR for EGFP- and mScarlet-
inserted AAVS alleles of single iPSC clones generated by CRISPR editing using non-split targeting constructs (TCs) 107 and 108. NT: Non-targeted; T:
Targeted pool; M: Marker=GeneRuler 1 kb+ ladder. d Genotyping PCR for EGFP- and mScarlet-inserted AAVS alleles of single iPSC clones generated by
CRISPR editing using Intres TCs 109 and 110. NT: Non-targeted; T: Targeted pool; M: Marker=GeneRuler 1 kb+ ladder. e Representative fluorescent
microscopic images of hiPSC colonies from the indicated clones derived from the Intres CRISPR experiments using TCs 109 and 110. Scale bar: 200 μm
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well as to confirm these inteins are indeed orthogonal, we con-
ducted western blot analysis of protein trans-splicing between N-
markertrons N-terminally tagged with 3xFLAG-epitope and C-
markertrons C-terminally tagged with HA-epitope (Supplemen-
tary Fig. 14). As expected, while cognate markertrons with
matching N- and C-inteins supported reconstitution of the full-
length HygroR (lanes 3,5,6), markertrons with unmatched N- and
C-inteins did not yield full-length HygroR (lanes 7,8). To intro-
duce and select cells with four or more transgenes, one approach
is through sequential transduction/selection of two or more sets
of 2-split Intres vectors. By subjecting cells to two rounds of 2-
split Intres transduction/selection (Hygro → Puro or Puro →
Hygro) with each round carrying two transgenes, we obtained
quadruple transgenic cells (Supplementary Fig. 15). These results
demonstrated that four transgenes can be sequentially introduced,
and that the Intres system is compatible with sequential cell
engineering. Another way to introduce four or more transgenes is
with higher-degree split Intres markers. By combining the mul-
tiple inteins and positions tested for HygroR, we designed and
tested 6-split Hygro Intres marker (Supplementary Fig. 16).
While cultures transduced with all markertrons yielded viable
cells, leave-one-out cultures missing any one of the markertrons
did not produce any viable cells after selection. This result
demonstrates that up to at least 6 transgenic vectors can be
selected simultaneously by one selection scheme using a split
selectable marker.
Proviral copy number analysis. We validated Intres lentiviral
vectors in additional cell lines (HEK293T and HeLa) (Supple-
mentary Fig. 17). To ask whether split markers require a sub-
stantially higher copy number than non-split markers to support
selection, we conducted proviral copy number analysis in non-
selective and selective cultures of cells transduced with non-split
HygroR or split Hygro Intres markers (Supplementary Fig. 18) in
U2OS, HEK293T and HeLa cells. In general, we observed 1.3–3.1-
fold proviral copy numbers in the split marker cultures compared
to the non-split cultures. Since the two-split markers require the
presence of the two different viral genomes hosting the two
markertrons to reconstitute a full resistance protein, it is expected
to have ~2-fold equivalence of viral integration to support
selection.
Discussion
In this study, we have engineered split antibiotic resistance and
fluorescent protein genes that allow selection for two or more
“unlinked” transgenes. By inserting unnatural residues at select-
able markers, we showed that additional high-efficiency split
points could be utilized, expanding the positions available for
engineering. We demonstrated that split selectable markers could
be incorporated into lentiviral vectors or gene targeting con-
structs in CRISPR-Cas9 genome editing experiments for positive
selection of cells with double transgenesis or biallelic knock-ins.
By combining two splits points, we showed that 3-split markers
could be generated to allow higher degree transgenic selection. By
conducting sequential transduction/selection with two-split
markers, or by combining even more split points we showed
the potential to use split selectable markers to select for 4 vectors
with two antibiotics or up to 6 vectors with one antibiotic
respectively. It is intriguing to anticipate future work to design
even higher-degree split selectable markers and to explore the
limit of this system for “hyper-engineering” of cells.
Methods
Cloning. To generate a test plasmid for each markertron, we first generated a
Gateway donor plasmid containing its ORF and then recombined into lentiviral
destination vector with TagBFP2 (Plasmid 94: pLX-DEST-IRES-TagBFP2), EGFP
(Plasmid 95: pLX-DEST-IRES-EGFP), or mCherry (Plasmid 96: pLX-DEST-IRES-
mCherry) reporters, which were derived from pLX302 (Gift from David Root;
Addgene: #25896) by removing Puromycin resistance gene and inserting IRES-
fluorescent genes downstream of the Gateway cassette. The markertron-ORF
Gateway donor plasmids were generated either by a nested fusion PCR procedure
to combine intein with the coding sequence of fragments of the selectable marker
followed by insertion into the pCR8-GW-TOPO plasmid by sequence- and
ligation-independent cloning (SLIC), or PCR-amplifying the relevant fragment of
the selectable marker followed by insertion into “scaffold” plasmids (Plasmids
27~32) containing the intein sequences by SLIC. DNA sequences encoding inteins
were codon optimized for Homo sapiens, and synthesized as GBlocks (IDT).
Selectable marker fragments were amplified from plasmids containing these mar-
kers. Plasmids created in this study are listed in Supplementary Table 1 with links
to webpages for plasmid sharing and GenBank sequence files.
HEK293T, U2OS, and HeLa cell cultures. HEK293T (ATCC® CRL-3216), U2OS
(ATCC® HTB-96™), HeLa (ATCC® CCL-2.2™) cells were cultivated in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma) with 10% fetal bovine serum (FBS)
(Lonza), 4% Glutamax (Gibco), 1% Sodium Pyruvate (Gibco), and penicillin-
streptomycin (Gibco). Incubator conditions were 37 °C and 5% CO2.
Virus Production. A viral packaging mix of pLP1, pLP2, and VSV-G were co-
transfected with each lentiviral vector into Lenti-X 293T cells (Clontech/Takara #
632180), seeded the day before in 6-well plates at a concentration of 1.2 × 106 cells
per well, using Lipofectamine 3000. Media was changed 6 h after transfection then
incubated overnight. 28 h post transfection, the media supernatant containing virus
was filtered using 45 μM PES filters then stored at −80 °C until use.
Transduction, transfection, flow cytometry, and microscopy. The day prior to
transduction, U2OS, HEK293T, or HeLa cells were seeded into 12-well plates at a
density of 1.5 × 105 cells per well. Prior to transduction, media was changed to
media containing 10 μg/mL polybrene, 1 mL per well. In all, 25 μL (or indicated
otherwise) of each respective virus (50 μL total for experimental samples with two
viruses or 75 μL total for experimental samples with three viruses) was added to
each well and incubated overnight. Media was changed 24 h post-transduction.
Four days post-transduction, cells were split into duplicate plates. Five days post-
transduction, media with antibiotics (130 μg/mL Hygromycin, 2 μg/mL Puromycin,
700 μg/mL G418, or 6 μg/mL Blasticidin) was added to each respective well of one
replicate plate (the other remained under no selection). Antibiotics selection
continued for 2 weeks before analysis with flow cytometry. For flow cytometry,
cells were trypsinized, suspended in media then analyzed on a LSRFortessa X-20 or
FACSymphony flow cytometers (BD Bioscience). Fifty thousand events were col-
lected each run. Examplary gating strategy is presented in Supplementary Fig. 19.
Microscopy images were taken with the iRiS Digital Cell Imaging System (Logos
Biosystems). For transfection for the CRISPR experiment in HEK293T, 600 ng of
total plasmids, in equal ratios, were mixed with 100 μL of DMEM and 1.5 μL of
attractene (QIAGEN), incubated at RT for 10 min then added to each well and
incubated overnight. Media was changed 24 h post-transfection. Two days post
transfection, cells were split into duplicate plates with media containing doxycy-
cline (2 μg/mL). Three days post transfection, media with doxycycline and anti-
biotics was added to each respective well of one replicate plate (the other remained
under no selection).
Human iPSC culture and nucleofection. Feeder-free KOLF2-C1 (gift from Bill
Skarnes, subclone of HipSci HPSI0114i-kolf_2) were maintained on plate coated
with Synthemax ll-SC Substrate (Corning) in StemFlex media (Thermo Fisher
Scientific). Subculture was carried out every 4–6 days via Accutase (STEMCELL)
detachment method. After plating, 1X RevitaCell supplement (Gibco Life Tech-
nologies) was added for 1 day to increase cell viability. For Cas9/gRNA ribonu-
cleoprotein (Cas9/gRNA RNPs) and donor plasmids nucleofection, 4D-
NucleofectorTM System (Lonza) was used with the P3 Primary Cell 4D-
Nucleofector kit (Lonza). Cells were at 60–70% confluency at the time of nucleo-
fection. To assemble Cas9/gRNA RNPs, synthetic single-guide RNA (Synthego)
was resuspended in TE buffer (Synthego) at 2 µg/µl, and 8 µl of stock solution was
mixed with 20 µg Cas9 protein before nucleofection. For each reaction, 2 × 106 cells
were collected, resuspended in 100 µl complete P3 solution and mixed with pre-
assembled Cas9/gRNA RNPs as well as donor plasmids DNA. Doxycycline (Sigma)
was added 6 days after nucleofection at 5 µg/mL. Two days after doxycycline was
added, 4 µg/mL Blasticidin (Sigma) was applied to select cells with resistance.
Surviving single colonies were picked and expanded into Matrigel-coated 24-well
plate. If surviving colonies were too large to be manually picked as single colony,
cells were replated onto new plate at the density of 2500 cells per 10 cm2 plate.
Blasticidin treatment continued during single colony expansion in 24-well plates.
For genotyping, genomic DNA was extracted using DNeasy Blood & Tissue Kit
(QIAGEN), and PCR was performed using the following primers to identify cor-
rectly targeted AAVS1 insertions: (i) EGFP-AAVS (fwd: GCCCGACAACC
ACTACCTGA, rev: GTGAGTTTGCCAAGCAGTCA), (ii) mScarlet-AAVS (fwd:
CTGAGGTCAAGACCACCTACAAG, rev: GTGAGTTTGCCAAGCAGTCA).
Uncropped gel photos are available within the Source Data file.
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Quantitation of proviral copy number in genomic DNA. Proviral copy number
was measured using Lenti-X Provirus Quantitation Kit (Takara). To perform the
analysis, genomic DNA was isolated from transduced cells with NucleoSpin Tissue
Genomic DNA Purification (Takara). Serial dilutions of each gDNA sample was
subjected to qPCR amplification alongside dilutions of a provirus control template
(provided in kit), which was used to generate a standard curve. Since the viral frag-
ments in gDNA and the control template would be amplified with different PCR
sensitivities, the provirus copy number was finally calculated based on the standard
curve and correlated with a correction factor (provided in manual by Takara).
Western Blot. Proteins were separated by 4–20% precast polyacrylamide gel then
transferred onto nitrocellulose membrane. After protein transfer, the membranes were
incubated in room temperature 5% non-fat milk for 1 h. Membranes were then
probed with antibodies against HA-epitope (#3724, 1:1000, Cell Signaling), FLAG-
epitope (#F7425, 1:1000, Millipore Sigma), and Vinculin (EPR8185, 1:2000, Abcam).
Proteins of interest were detected with HRP-conjugated anti-mouse (9044, 1:20,000,
Sigma) and anti-rabbit (0545, 1:20,000, Sigma) and visualized with ClarityTMWestern
ECL Substrate. Uncropped scans of blots are available in the Source Data file.
Crystal violet assay. After virus infection, cells were seeded at 10–15% confluency
into 12-well plates in parallel and cultured in hygromycin selection media. Media
was changed every 3 days during selection. Crystal violet staining were applied on
day0, day3, day5, day7 as well as day14. If cells were greater than 80% (as in the
case of sample 1 of Supplementary Fig. 16) confluent on day7, they were split at a
1:20 ratio. For Crystal violet staining, each well was stained with 500 μl 0.1% crystal
violet (Sigma) for 10 min at room temperature, then washed gently with 500 μl
DPBS for three times before the photographs were taken with an iPhone.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. Plasmids created in this study are listed in
Supplementary Table 1 with links to webpages for plasmid sharing and GenBank
sequence files. The source data underlying Fig. 5 and Supplementary Figs. S1b, S14b as
well as raw plot numbers are provided as a Source Data file.
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